DHX9 and cancer: Additionally, the subset of MYXV-restricted human cancer cells where the DHX9 pathway is fully active can be converted from a restrictive to a more MYXV-permissive phenotype by selectively inhibiting DHX9 or by blocking the signaling pathway.